These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28407875)

  • 1. Mendelian randomization to establish the causality of uric acid with diabetic nephropathy in type 1 diabetics.
    Gul A; Harford A; Zager P
    Kidney Int; 2017 May; 91(5):1005-1007. PubMed ID: 28407875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serum uric acid concentration is not causally linked to diabetic nephropathy in type 1 diabetes.
    Ahola AJ; Sandholm N; Forsblom C; Harjutsalo V; Dahlström E; Groop PH;
    Kidney Int; 2017 May; 91(5):1178-1185. PubMed ID: 28238338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A causal relationship between uric acid and diabetic macrovascular disease in Chinese type 2 diabetes patients: A Mendelian randomization analysis.
    Yan D; Wang J; Jiang F; Zhang R; Wang T; Wang S; Peng D; He Z; Chen H; Bao Y; Hu C; Jia W
    Int J Cardiol; 2016 Jul; 214():194-9. PubMed ID: 27064641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum uric acid as a new player in the development of diabetic nephropathy.
    Hovind P; Rossing P; Johnson RJ; Parving HH
    J Ren Nutr; 2011 Jan; 21(1):124-7. PubMed ID: 21195935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Altered Uric Acid Metabolism Contribute to Diabetic Kidney Disease Pathophysiology?
    Gul A; Zager P
    Curr Diab Rep; 2018 Mar; 18(4):18. PubMed ID: 29497863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically Determined Uric Acid and the Risk of Cardiovascular and Neurovascular Diseases: A Mendelian Randomization Study of Outcomes Investigated in Randomized Trials.
    Efstathiadou A; Gill D; McGrane F; Quinn T; Dawson J
    J Am Heart Assoc; 2019 Sep; 8(17):e012738. PubMed ID: 31438759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid and cardiovascular risk: What genes can say.
    Kei A; Koutsouka F; Makri A; Elisaf M
    Int J Clin Pract; 2018 Jan; 72(1):. PubMed ID: 29250870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum uric acid with level of blood pressure in type 2 diabetic patients.
    Rafieian-Kopaei M; Behradmanesh S; Kheiri S; Nasri H
    Iran J Kidney Dis; 2014 Mar; 8(2):152-4. PubMed ID: 24685739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric Acid and Cardiovascular Events: A Mendelian Randomization Study.
    Kleber ME; Delgado G; Grammer TB; Silbernagel G; Huang J; Krämer BK; Ritz E; März W
    J Am Soc Nephrol; 2015 Nov; 26(11):2831-8. PubMed ID: 25788527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations of serum uric acid with glucose and lipid metabolism and renal function of type 2 diabetes mellitus patients.
    Jiao X; Zhang G; Li G; Yin X; Shen X
    Panminerva Med; 2020 Jun; 62(2):121-123. PubMed ID: 31089084
    [No Abstract]   [Full Text] [Related]  

  • 11. Fructose and uric acid in diabetic nephropathy.
    Bjornstad P; Lanaspa MA; Ishimoto T; Kosugi T; Kume S; Jalal D; Maahs DM; Snell-Bergeon JK; Johnson RJ; Nakagawa T
    Diabetologia; 2015 Sep; 58(9):1993-2002. PubMed ID: 26049401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uric Acid is independently associated with diabetic kidney disease: a cross-sectional study in a Chinese population.
    Yan D; Tu Y; Jiang F; Wang J; Zhang R; Sun X; Wang T; Wang S; Bao Y; Hu C; Jia W
    PLoS One; 2015; 10(6):e0129797. PubMed ID: 26029914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing serum uric acid attenuates TGF-β1-induced profibrogenic progression in type 2 diabetic nephropathy.
    Kim SM; Choi YW; Seok HY; Jeong KH; Lee SH; Lee TW; Ihm CG; Lim SJ; Moon JY
    Nephron Exp Nephrol; 2012; 121(3-4):e109-21. PubMed ID: 23307286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum uric acid predicts cardiovascular mortality in male peritoneal dialysis patients with diabetes.
    Xia X; Zhao C; Peng FF; Luo QM; Zhou Q; Lin ZC; Yu XQ; Huang FX
    Nutr Metab Cardiovasc Dis; 2016 Jan; 26(1):20-6. PubMed ID: 26712272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes: Lowering serum uric acid levels to prevent kidney failure.
    Doria A; Krolewski AS
    Nat Rev Nephrol; 2011 Aug; 7(9):495-6. PubMed ID: 21808278
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum uric acid as prognostic marker of coronary heart disease (CHD).
    Purnima S; El-Aal BG
    Clin Investig Arterioscler; 2016; 28(5):216-224. PubMed ID: 27663421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to target uric acid to retard CKD progression.
    Kumagai T; Ota T; Tamura Y; Chang WX; Shibata S; Uchida S
    Clin Exp Nephrol; 2017 Apr; 21(2):182-192. PubMed ID: 27339448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genetic marker of uric acid level, carotid atherosclerosis, and arterial stiffness: a family-based study.
    Mallamaci F; Testa A; Leonardis D; Tripepi R; Pisano A; Spoto B; Sanguedolce MC; Parlongo RM; Tripepi G; Zoccali C
    Am J Kidney Dis; 2015 Feb; 65(2):294-302. PubMed ID: 25301104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Sodium Glucose Cotransporter-2 Inhibitors on Serum Uric Acid in Type 2 Diabetes Mellitus.
    Ahmadieh H; Azar S
    Diabetes Technol Ther; 2017 Sep; 19(9):507-512. PubMed ID: 28749169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.
    Bartáková V; Kuricová K; Pácal L; Nová Z; Dvořáková V; Švrčková M; Malúšková D; Svobodová I; Řehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
    J Diabetes Complications; 2016; 30(7):1300-7. PubMed ID: 27324705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.